MA29103B1 - Agents cytotoxiques comprenant de nouveaux taxanes - Google Patents

Agents cytotoxiques comprenant de nouveaux taxanes

Info

Publication number: MA29103B1
Authority: MA; Morocco
Prior art keywords: cytotoxic agents; new taxanes; taxanes; new; cytotoxic
Prior art date: 2004-12-07

Application number

MA30008A

Other languages

English (en)

Inventor

Michael L Miller

Ravi V J Chari

Erkan Baloglu

Alain Commercon

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-07

Filing date

2007-06-18

Publication date

2007-12-03

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34931583&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA29103(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-06-18 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2007-12-03 Publication of MA29103B1 publication Critical patent/MA29103B1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Mycology (AREA)
Microbiology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Epoxy Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Plural Heterocyclic Compounds (AREA)

MA30008A 2004-12-07 2007-06-18 Agents cytotoxiques comprenant de nouveaux taxanes MA29103B1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP04292898A EP1669358A1 (fr)	2004-12-07	2004-12-07	Agents cytotoxiques comprenant des nouveau taxanes

Publications (1)

Publication Number	Publication Date
MA29103B1 true MA29103B1 (fr)	2007-12-03

Family

ID=34931583

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA30008A MA29103B1 (fr)	2004-12-07	2007-06-18	Agents cytotoxiques comprenant de nouveaux taxanes

Country Status (22)

Country	Link
US (1)	US7667054B2 (fr)
EP (2)	EP1669358A1 (fr)
JP (1)	JP2008523019A (fr)
KR (1)	KR20070085781A (fr)
CN (1)	CN101094857A (fr)
AR (1)	AR054100A1 (fr)
AU (1)	AU2005313444B2 (fr)
BR (1)	BRPI0518869A2 (fr)
CA (1)	CA2588587A1 (fr)
DO (1)	DOP2005000248A (fr)
EA (1)	EA012625B1 (fr)
IL (1)	IL183404A0 (fr)
MA (1)	MA29103B1 (fr)
MX (1)	MX2007006765A (fr)
MY (1)	MY144632A (fr)
NO (1)	NO20073033L (fr)
NZ (1)	NZ555406A (fr)
PE (2)	PE20110001A1 (fr)
TW (1)	TW200637836A (fr)
UY (1)	UY29249A1 (fr)
WO (1)	WO2006061258A2 (fr)
ZA (1)	ZA200704790B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE446317T1 (de)	2001-05-11	2009-11-15	Ludwig Inst For Cancer Res Ltd	Spezifische bindungsproteine und ihre verwendung
US20100056762A1 (en)	2001-05-11	2010-03-04	Old Lloyd J	Specific binding proteins and uses thereof
CN110613845B (zh) *	2007-01-25	2025-08-26	达娜-法勃肿瘤研究所公司	抗egfr抗体在治疗egfr突变体介导的疾病中的用途
US20080207743A1 (en) *	2007-02-28	2008-08-28	Rodger Lamb	Biologically Active Taxane Analogs and Methods of Treatment
ES2542152T3 (es) *	2007-03-15	2015-07-31	Ludwig Institute For Cancer Research Ltd.	Método de tratamiento que emplea anticuerpos de EGFR e inhibidores de Src y formulaciones relacionadas
US9283276B2 (en)	2007-08-14	2016-03-15	Ludwig Institute For Cancer Research Ltd.	Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof
FR2947269B1 (fr)	2009-06-29	2013-01-18	Sanofi Aventis	Nouveaux composes anticancereux
FR2949469A1 (fr)	2009-08-25	2011-03-04	Sanofi Aventis	Derives anticancereux, leur preparation et leur application en therapeutique
US20110076232A1 (en) *	2009-09-29	2011-03-31	Ludwig Institute For Cancer Research	Specific binding proteins and uses thereof
TW201117814A (en)	2009-10-02	2011-06-01	Sanofi Aventis	New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody
CN101851231A (zh) *	2010-05-27	2010-10-06	东北林业大学	一种多西紫杉醇新衍生物的合成方法及其在制备抗肿瘤药物中的应用
FR2963007B1 (fr)	2010-07-26	2013-04-05	Sanofi Aventis	Derives anticancereux, leur preparation et leur application therapeutique
ES2939836T3 (es)	2012-07-12	2023-04-27	Hangzhou Dac Biotech Co Ltd	Conjugados de moléculas de unión celular con agentes citotóxicos
CN105849086B (zh)	2012-11-24	2018-07-31	杭州多禧生物科技有限公司	亲水性链接体及其在药物分子和细胞结合分子共轭反应上的应用
CN114262344A (zh)	2014-02-28	2022-04-01	杭州多禧生物科技有限公司	带电荷链接体及其在共轭反应上的应用
CN104693156A (zh) *	2014-10-22	2015-06-10	上海大学	9,10-二羟基-1-去氧紫杉醇类似物及其制备方法
CA2991973C (fr)	2015-07-12	2021-12-07	Suzhou M-Conj Biotech Co., Ltd.	Lieurs de pontage pour la conjugaison d'une molecule de liaison cellulaire
US9839687B2 (en)	2015-07-15	2017-12-12	Suzhou M-Conj Biotech Co., Ltd.	Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
NZ752394A (en)	2016-11-14	2021-07-30	Hangzhou Dac Biotech Co Ltd	Conjugation linkers, cell binding molecule-drug conjugates containing the likers, methods of making and uses such conjugates with the linkers
KR20240095442A (ko)	2021-11-03	2024-06-25	항저우 디에이씨 바이오테크 씨오, 엘티디	항체의 특이적 접합

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5703247A (en) *	1993-03-11	1997-12-30	Virginia Tech Intellectual Properties, Inc.	2-Debenzoyl-2-acyl taxol derivatives and methods for making same
FR2742751B1 (fr) *	1995-12-22	1998-01-30	Rhone Poulenc Rorer Sa	Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
AU765588C (en) *	1999-11-24	2004-12-16	Immunogen, Inc.	Cytotoxic agents comprising taxanes and their therapeutic use
US6596757B1 (en) *	2002-05-14	2003-07-22	Immunogen Inc.	Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use
AU2003247587B2 (en) *	2002-08-02	2009-07-09	Immunogen, Inc.	Cytotoxic agents containing novel potent taxanes and their therapeutic use

2004
- 2004-12-07 EP EP04292898A patent/EP1669358A1/fr not_active Withdrawn
2005
- 2005-11-29 PE PE2010000952A patent/PE20110001A1/es not_active Application Discontinuation
- 2005-11-29 PE PE2005001385A patent/PE20061060A1/es not_active Application Discontinuation
- 2005-12-01 MY MYPI20055612A patent/MY144632A/en unknown
- 2005-12-02 CA CA002588587A patent/CA2588587A1/fr not_active Abandoned
- 2005-12-02 CN CNA200580045888XA patent/CN101094857A/zh active Pending
- 2005-12-02 EA EA200701251A patent/EA012625B1/ru not_active IP Right Cessation
- 2005-12-02 MX MX2007006765A patent/MX2007006765A/es active IP Right Grant
- 2005-12-02 EP EP05843730A patent/EP1824858A2/fr not_active Withdrawn
- 2005-12-02 NZ NZ555406A patent/NZ555406A/en not_active IP Right Cessation
- 2005-12-02 JP JP2007544849A patent/JP2008523019A/ja active Pending
- 2005-12-02 ZA ZA200704790A patent/ZA200704790B/xx unknown
- 2005-12-02 BR BRPI0518869-5A patent/BRPI0518869A2/pt not_active IP Right Cessation
- 2005-12-02 AU AU2005313444A patent/AU2005313444B2/en not_active Expired - Fee Related
- 2005-12-02 KR KR1020077012679A patent/KR20070085781A/ko not_active Ceased
- 2005-12-02 WO PCT/EP2005/014177 patent/WO2006061258A2/fr not_active Ceased
- 2005-12-05 AR ARP050105077A patent/AR054100A1/es unknown
- 2005-12-06 US US11/295,294 patent/US7667054B2/en not_active Expired - Fee Related
- 2005-12-06 TW TW094142849A patent/TW200637836A/zh unknown
- 2005-12-06 DO DO2005P000248A patent/DOP2005000248A/es unknown
- 2005-12-07 UY UY29249A patent/UY29249A1/es unknown
2007
- 2007-05-24 IL IL183404A patent/IL183404A0/en unknown
- 2007-06-14 NO NO20073033A patent/NO20073033L/no not_active Application Discontinuation
- 2007-06-18 MA MA30008A patent/MA29103B1/fr unknown

Also Published As

Publication number	Publication date
IL183404A0 (en)	2007-10-31
EP1669358A1 (fr)	2006-06-14
NO20073033L (no)	2007-08-28
KR20070085781A (ko)	2007-08-27
CN101094857A (zh)	2007-12-26
PE20061060A1 (es)	2006-11-14
JP2008523019A (ja)	2008-07-03
ZA200704790B (en)	2008-08-27
NZ555406A (en)	2011-02-25
AU2005313444A1 (en)	2006-06-15
US20060178427A1 (en)	2006-08-10
US7667054B2 (en)	2010-02-23
AU2005313444B2 (en)	2011-11-10
UY29249A1 (es)	2006-06-30
TW200637836A (en)	2006-11-01
EP1824858A2 (fr)	2007-08-29
MY144632A (en)	2011-10-14
AR054100A1 (es)	2007-06-06
WO2006061258A2 (fr)	2006-06-15
EA200701251A1 (ru)	2007-12-28
DOP2005000248A (es)	2007-02-15
EA012625B1 (ru)	2009-10-30
BRPI0518869A2 (pt)	2008-12-16
WO2006061258A3 (fr)	2006-09-28
PE20110001A1 (es)	2011-01-21
MX2007006765A (es)	2007-08-16
CA2588587A1 (fr)	2006-06-15

Publication	Publication Date	Title
MA29103B1 (fr)	2007-12-03	Agents cytotoxiques comprenant de nouveaux taxanes
MA28948B1 (fr)	2007-10-01	Composition pesticide
EP1788047A4 (fr)	2011-12-21	Composition hydrofuge/oleofuge
EP1719409A4 (fr)	2010-09-22	Composition insecticide
EP1893244A4 (fr)	2009-06-24	Agents pour l'imagerie
FI20050565L (fi)	2005-11-30	Ohjaussauvajärjestely
DK1740484T3 (da)	2009-07-20	Platform
DE602005008239D1 (de)	2008-08-28	Gepfropfte fluorelastomere
EP2111484A4 (fr)	2009-10-28	Agent de brillance polyamine
BRPI0508066B1 (pt)	2013-12-24	Pesticida de piretróide
DE602005018577D1 (de)	2010-02-11	Armstütze
UY3546Q (es)	2006-01-31	Maquina de juego
DE202005000407U1 (de)	2005-03-24	Arbeitsbühne
UY3548Q (es)	2006-01-31	Maquina de juego
FR2871686B1 (fr)	2008-02-29	Composition anti-decoloration
ITMI20041447A1 (it)	2004-10-20	Composizione farmaceutica comprendente gabapentina
ITMI20040943A1 (it)	2004-08-11	Composizione farmaceutica cicatrizzante
NO20052428D0 (no)	2005-05-20	Kontrastmidler
NO20042486L (no)	2005-12-15	Novel contrast agent
DE602005001303D1 (de)	2007-07-19	Pestizide Zusammensetzung
AT500775B2 (de)	2006-10-15	Spielkonsole
ES1058047Y (es)	2005-02-01	Juego de helice
SE0400990D0 (sv)	2004-04-18	Läkemedel
ES1056992Y (es)	2004-09-16	Juego de construccion.
UY3547Q (es)	2006-01-31	Maquina de juego